Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,022 | -12,949 | -8,279 | -4,594 | -15,365 |
| Depreciation Amortization | 38 | 19 | 13 | 6 | 17 |
| Accounts receivable | 399 | 728 | -33 | 338 | -786 |
| Accounts payable and accrued liabilities | -583 | -515 | -1,046 | -445 | 234 |
| Other Working Capital | -241 | 140 | -1,172 | -77 | -506 |
| Other Operating Activity | 923 | 65 | 865 | 824 | 3,157 |
| Operating Cash Flow | $-15,486 | $-12,512 | $-9,652 | $-3,948 | $-13,249 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,000 | 25 | N/A | N/A | 10,000 |
| PPE Investments | -18 | -12 | -10 | -8 | -48 |
| Sale Of Investment | N/A | 5,046 | 5,000 | N/A | N/A |
| Investing Cash Flow | $8,982 | $5,059 | $4,990 | $-8 | $9,952 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,089 | 6,090 | 6,090 | 6,196 | N/A |
| Financing Cash Flow | $6,089 | $6,090 | $6,090 | $6,196 | $N/A |
| Beginning Cash Position | 7,286 | 7,286 | 7,286 | 7,286 | 10,583 |
| End Cash Position | 6,871 | 5,923 | 8,714 | 9,526 | 7,286 |
| Net Cash Flow | $-415 | $-1,363 | $1,428 | $2,240 | $-3,297 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,486 | -12,512 | -9,652 | -3,948 | -13,249 |
| Capital Expenditure | -18 | -12 | -10 | -8 | -48 |
| Free Cash Flow | -15,504 | -12,524 | -9,662 | -3,956 | -13,297 |